Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HSP70 Heat-Shock Proteins | 6 | 2017 | 26 | 2.820 |
Why?
|
| Insulin Resistance | 15 | 2019 | 462 | 2.750 |
Why?
|
| Aging | 10 | 2020 | 946 | 2.550 |
Why?
|
| Liver | 9 | 2019 | 484 | 2.390 |
Why?
|
| Fructose | 5 | 2019 | 11 | 1.980 |
Why?
|
| Endotoxemia | 4 | 2016 | 7 | 1.910 |
Why?
|
| Fatty Liver | 4 | 2014 | 66 | 1.730 |
Why?
|
| Blood Glucose | 14 | 2020 | 494 | 1.670 |
Why?
|
| Animals | 46 | 2020 | 7542 | 1.590 |
Why?
|
| Obesity | 8 | 2019 | 1176 | 1.590 |
Why?
|
| Adipose Tissue | 4 | 2020 | 349 | 1.540 |
Why?
|
| Whole-Body Irradiation | 3 | 2019 | 53 | 1.280 |
Why?
|
| Muscle, Skeletal | 5 | 2016 | 519 | 1.160 |
Why?
|
| Prediabetic State | 3 | 2020 | 65 | 1.100 |
Why?
|
| Motor Activity | 2 | 2019 | 325 | 1.020 |
Why?
|
| Diabetes Mellitus, Experimental | 5 | 2011 | 54 | 0.930 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2020 | 1428 | 0.910 |
Why?
|
| Insulin | 9 | 2014 | 367 | 0.880 |
Why?
|
| Glucose | 3 | 2017 | 174 | 0.750 |
Why?
|
| Female | 27 | 2020 | 20015 | 0.740 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2020 | 45 | 0.730 |
Why?
|
| Quadriceps Muscle | 1 | 2020 | 34 | 0.730 |
Why?
|
| Liver Cirrhosis | 2 | 2019 | 81 | 0.710 |
Why?
|
| Disease Models, Animal | 10 | 2020 | 1022 | 0.710 |
Why?
|
| Subcutaneous Fat | 2 | 2017 | 47 | 0.670 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 32 | 0.670 |
Why?
|
| Trans Fatty Acids | 2 | 2010 | 10 | 0.660 |
Why?
|
| Bacterial Infections | 1 | 2019 | 51 | 0.650 |
Why?
|
| Amniotic Fluid | 1 | 2019 | 86 | 0.640 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 245 | 0.640 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 18 | 0.630 |
Why?
|
| Macaca fascicularis | 10 | 2017 | 434 | 0.620 |
Why?
|
| Bacteria | 1 | 2018 | 48 | 0.610 |
Why?
|
| Mobility Limitation | 1 | 2019 | 219 | 0.600 |
Why?
|
| Medicago sativa | 1 | 2017 | 2 | 0.600 |
Why?
|
| Inflammation | 3 | 2019 | 530 | 0.580 |
Why?
|
| Hot Temperature | 2 | 2019 | 71 | 0.570 |
Why?
|
| Exercise Therapy | 1 | 2019 | 270 | 0.570 |
Why?
|
| Body Weight | 10 | 2016 | 310 | 0.570 |
Why?
|
| Lipids | 8 | 2016 | 232 | 0.570 |
Why?
|
| Haplorhini | 5 | 2018 | 68 | 0.560 |
Why?
|
| Hydrotherapy | 1 | 2016 | 4 | 0.550 |
Why?
|
| Body Composition | 6 | 2019 | 397 | 0.530 |
Why?
|
| Muscles | 1 | 2016 | 62 | 0.530 |
Why?
|
| Intestinal Mucosa | 1 | 2016 | 71 | 0.520 |
Why?
|
| Male | 23 | 2020 | 19217 | 0.510 |
Why?
|
| Sarcopenia | 1 | 2016 | 64 | 0.510 |
Why?
|
| Mitochondria | 1 | 2017 | 187 | 0.510 |
Why?
|
| Glucose Tolerance Test | 8 | 2016 | 126 | 0.510 |
Why?
|
| Energy Metabolism | 1 | 2016 | 147 | 0.500 |
Why?
|
| Hypoglycemic Agents | 4 | 2011 | 181 | 0.490 |
Why?
|
| Physical Endurance | 1 | 2014 | 36 | 0.480 |
Why?
|
| Glucose Intolerance | 2 | 2011 | 46 | 0.460 |
Why?
|
| Muscle Strength | 1 | 2014 | 161 | 0.440 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2013 | 14 | 0.440 |
Why?
|
| Streptozocin | 2 | 2011 | 8 | 0.410 |
Why?
|
| Estrogens, Conjugated (USP) | 2 | 2009 | 140 | 0.390 |
Why?
|
| Weight Gain | 2 | 2013 | 117 | 0.380 |
Why?
|
| Isoflavones | 2 | 2008 | 81 | 0.380 |
Why?
|
| Soybean Proteins | 2 | 2008 | 74 | 0.380 |
Why?
|
| Overweight | 1 | 2013 | 280 | 0.380 |
Why?
|
| Dietary Fats | 2 | 2011 | 110 | 0.370 |
Why?
|
| Growth | 1 | 2010 | 6 | 0.360 |
Why?
|
| Growth Disorders | 1 | 2010 | 5 | 0.360 |
Why?
|
| Fluid Shifts | 1 | 2010 | 2 | 0.360 |
Why?
|
| PPAR gamma | 1 | 2010 | 46 | 0.350 |
Why?
|
| Fibrosis | 2 | 2020 | 120 | 0.350 |
Why?
|
| Thiazolidinediones | 1 | 2010 | 47 | 0.350 |
Why?
|
| Sterol O-Acyltransferase | 1 | 2009 | 11 | 0.350 |
Why?
|
| Menopause | 2 | 2013 | 95 | 0.340 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2010 | 92 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 767 | 0.330 |
Why?
|
| Adiponectin | 5 | 2017 | 106 | 0.330 |
Why?
|
| Hyperinsulinism | 1 | 2008 | 13 | 0.310 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2008 | 25 | 0.310 |
Why?
|
| Phytotherapy | 1 | 2008 | 38 | 0.310 |
Why?
|
| Soybeans | 1 | 2008 | 35 | 0.310 |
Why?
|
| Macaca mulatta | 3 | 2019 | 305 | 0.300 |
Why?
|
| Plant Extracts | 1 | 2008 | 61 | 0.300 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2019 | 81 | 0.300 |
Why?
|
| Pregnancy | 4 | 2020 | 997 | 0.300 |
Why?
|
| Intra-Abdominal Fat | 2 | 2020 | 63 | 0.290 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2011 | 633 | 0.280 |
Why?
|
| Atherosclerosis | 2 | 2011 | 766 | 0.280 |
Why?
|
| Insulin-Secreting Cells | 3 | 2011 | 53 | 0.270 |
Why?
|
| Animal Feed | 3 | 2019 | 16 | 0.260 |
Why?
|
| Hyperglycemia | 3 | 2011 | 84 | 0.260 |
Why?
|
| Carbohydrates | 1 | 2005 | 8 | 0.260 |
Why?
|
| Hormones | 1 | 2005 | 22 | 0.260 |
Why?
|
| Diet, Fat-Restricted | 2 | 2017 | 31 | 0.250 |
Why?
|
| Iron | 2 | 2019 | 116 | 0.250 |
Why?
|
| Homeostasis | 2 | 2015 | 132 | 0.230 |
Why?
|
| Primates | 3 | 2020 | 108 | 0.230 |
Why?
|
| Endpoint Determination | 3 | 2013 | 20 | 0.220 |
Why?
|
| Cholesterol, Dietary | 2 | 2014 | 36 | 0.220 |
Why?
|
| Diterpenes | 2 | 2014 | 20 | 0.210 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 495 | 0.210 |
Why?
|
| Lipid Metabolism | 2 | 2013 | 105 | 0.190 |
Why?
|
| Mice | 4 | 2019 | 2484 | 0.190 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 41 | 0.180 |
Why?
|
| Peanut Hypersensitivity | 1 | 2020 | 2 | 0.180 |
Why?
|
| Allergens | 1 | 2020 | 15 | 0.180 |
Why?
|
| Immunoglobulin E | 1 | 2020 | 37 | 0.180 |
Why?
|
| Adaptation, Physiological | 1 | 2020 | 55 | 0.180 |
Why?
|
| Energy Intake | 2 | 2013 | 128 | 0.180 |
Why?
|
| Signal Transduction | 2 | 2020 | 682 | 0.170 |
Why?
|
| Lipolysis | 1 | 2019 | 18 | 0.170 |
Why?
|
| Iron, Dietary | 1 | 2019 | 13 | 0.170 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 122 | 0.170 |
Why?
|
| Weight Loss | 3 | 2019 | 480 | 0.170 |
Why?
|
| Adiposity | 2 | 2010 | 198 | 0.160 |
Why?
|
| Immunoglobulins | 1 | 2018 | 15 | 0.160 |
Why?
|
| Disease Susceptibility | 1 | 2018 | 57 | 0.160 |
Why?
|
| Cattle | 1 | 2018 | 103 | 0.160 |
Why?
|
| Area Under Curve | 2 | 2016 | 93 | 0.160 |
Why?
|
| Monkey Diseases | 2 | 2010 | 20 | 0.150 |
Why?
|
| Colon | 1 | 2018 | 51 | 0.150 |
Why?
|
| Fasting | 2 | 2016 | 95 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 28 | 0.150 |
Why?
|
| Stress, Physiological | 2 | 2017 | 55 | 0.150 |
Why?
|
| Administration, Intranasal | 1 | 2017 | 31 | 0.150 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 102 | 0.150 |
Why?
|
| Fluorescent Dyes | 1 | 2017 | 48 | 0.150 |
Why?
|
| Middle Aged | 3 | 2019 | 11839 | 0.140 |
Why?
|
| Macrophage Activation | 1 | 2017 | 11 | 0.140 |
Why?
|
| Bacteriuria | 1 | 2017 | 4 | 0.140 |
Why?
|
| Copper | 1 | 2017 | 12 | 0.140 |
Why?
|
| Host-Pathogen Interactions | 1 | 2017 | 24 | 0.140 |
Why?
|
| Proteomics | 1 | 2017 | 94 | 0.140 |
Why?
|
| Urinary Tract | 1 | 2017 | 22 | 0.140 |
Why?
|
| Time Factors | 3 | 2020 | 2151 | 0.140 |
Why?
|
| Bacterial Translocation | 1 | 2016 | 9 | 0.140 |
Why?
|
| Gamma Rays | 1 | 2016 | 25 | 0.140 |
Why?
|
| Intestines | 1 | 2016 | 61 | 0.130 |
Why?
|
| Cardiovascular System | 1 | 2016 | 43 | 0.130 |
Why?
|
| Adipocytes | 2 | 2014 | 81 | 0.130 |
Why?
|
| Pedigree | 2 | 2013 | 140 | 0.130 |
Why?
|
| Macrophages | 1 | 2017 | 191 | 0.130 |
Why?
|
| Myocardium | 1 | 2016 | 186 | 0.130 |
Why?
|
| Heart | 1 | 2016 | 177 | 0.120 |
Why?
|
| Triglycerides | 3 | 2010 | 230 | 0.120 |
Why?
|
| Risk | 1 | 2015 | 321 | 0.120 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 2265 | 0.120 |
Why?
|
| Lipoproteins | 2 | 2014 | 86 | 0.110 |
Why?
|
| Random Allocation | 1 | 2014 | 228 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2014 | 56 | 0.110 |
Why?
|
| Metagenome | 1 | 2013 | 5 | 0.110 |
Why?
|
| Humans | 7 | 2019 | 32114 | 0.110 |
Why?
|
| Aged | 2 | 2019 | 10314 | 0.110 |
Why?
|
| Models, Animal | 1 | 2014 | 169 | 0.110 |
Why?
|
| Lipoproteins, LDL | 2 | 2013 | 81 | 0.110 |
Why?
|
| Cercopithecinae | 1 | 2013 | 2 | 0.110 |
Why?
|
| Diet | 2 | 2013 | 391 | 0.110 |
Why?
|
| Piperidines | 2 | 2010 | 118 | 0.100 |
Why?
|
| Hyperthermia, Induced | 1 | 2014 | 243 | 0.100 |
Why?
|
| Retrospective Studies | 1 | 2019 | 3510 | 0.100 |
Why?
|
| Women's Health | 1 | 2013 | 235 | 0.100 |
Why?
|
| Arginine | 1 | 2011 | 17 | 0.100 |
Why?
|
| Superoxides | 1 | 2011 | 19 | 0.090 |
Why?
|
| Genotype | 1 | 2013 | 733 | 0.090 |
Why?
|
| Heat Stress Disorders | 1 | 2011 | 11 | 0.090 |
Why?
|
| Triazines | 1 | 2010 | 3 | 0.090 |
Why?
|
| Arteries | 1 | 2011 | 67 | 0.090 |
Why?
|
| Azetidines | 1 | 2010 | 10 | 0.090 |
Why?
|
| Anti-Obesity Agents | 1 | 2010 | 6 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2011 | 229 | 0.090 |
Why?
|
| Lactation | 1 | 2010 | 16 | 0.090 |
Why?
|
| Milk, Human | 1 | 2010 | 16 | 0.090 |
Why?
|
| Body Water | 1 | 2010 | 8 | 0.090 |
Why?
|
| Propionates | 1 | 2010 | 3 | 0.090 |
Why?
|
| Pancreas | 1 | 2011 | 103 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 147 | 0.090 |
Why?
|
| Extracellular Fluid | 1 | 2010 | 11 | 0.090 |
Why?
|
| Extracellular Space | 1 | 2010 | 25 | 0.090 |
Why?
|
| Abdominal Fat | 1 | 2010 | 50 | 0.090 |
Why?
|
| C-Peptide | 2 | 2011 | 29 | 0.090 |
Why?
|
| Animals, Newborn | 1 | 2010 | 114 | 0.090 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2010 | 56 | 0.090 |
Why?
|
| PPAR alpha | 1 | 2010 | 29 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 84 | 0.090 |
Why?
|
| Analysis of Variance | 1 | 2011 | 464 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2011 | 181 | 0.090 |
Why?
|
| Absorptiometry, Photon | 1 | 2010 | 143 | 0.090 |
Why?
|
| Islets of Langerhans | 1 | 2010 | 76 | 0.090 |
Why?
|
| Apoptosis | 1 | 2011 | 360 | 0.080 |
Why?
|
| Seeds | 1 | 2008 | 10 | 0.080 |
Why?
|
| European Continental Ancestry Group | 1 | 2013 | 1166 | 0.080 |
Why?
|
| Thyroxine | 1 | 2008 | 16 | 0.080 |
Why?
|
| Positron-Emission Tomography | 1 | 2009 | 163 | 0.080 |
Why?
|
| Premenopause | 1 | 2008 | 44 | 0.080 |
Why?
|
| Cholesterol, HDL | 1 | 2008 | 177 | 0.070 |
Why?
|
| Body Size | 1 | 2007 | 34 | 0.070 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2007 | 102 | 0.070 |
Why?
|
| Phenotype | 2 | 2020 | 632 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2007 | 105 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2007 | 173 | 0.070 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2007 | 199 | 0.070 |
Why?
|
| African Americans | 1 | 2013 | 1425 | 0.070 |
Why?
|
| Fructosamine | 1 | 2005 | 5 | 0.070 |
Why?
|
| Androstenedione | 1 | 2005 | 5 | 0.070 |
Why?
|
| Estrone | 1 | 2005 | 8 | 0.070 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2005 | 8 | 0.070 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2005 | 28 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 130 | 0.060 |
Why?
|
| Ovariectomy | 1 | 2005 | 166 | 0.060 |
Why?
|
| Estradiol | 1 | 2005 | 136 | 0.060 |
Why?
|
| Maternal Age | 1 | 2020 | 15 | 0.050 |
Why?
|
| Histamine | 1 | 2020 | 3 | 0.040 |
Why?
|
| Anaphylaxis | 1 | 2020 | 12 | 0.040 |
Why?
|
| Teichoic Acids | 1 | 2019 | 8 | 0.040 |
Why?
|
| Cell Wall | 1 | 2019 | 7 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2019 | 20 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2019 | 26 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 109 | 0.040 |
Why?
|
| Risk Factors | 1 | 2007 | 3880 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 538 | 0.040 |
Why?
|
| Skin | 1 | 2020 | 211 | 0.040 |
Why?
|
| Reference Standards | 1 | 2017 | 32 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2017 | 37 | 0.040 |
Why?
|
| Ceruloplasmin | 1 | 2017 | 5 | 0.040 |
Why?
|
| Ions | 1 | 2017 | 12 | 0.040 |
Why?
|
| Disease Progression | 1 | 2019 | 594 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2017 | 135 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2020 | 845 | 0.030 |
Why?
|
| Cognition | 1 | 2019 | 556 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2014 | 27 | 0.030 |
Why?
|
| Cell Size | 1 | 2014 | 38 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2014 | 81 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 19 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2014 | 34 | 0.030 |
Why?
|
| Fever | 1 | 2014 | 61 | 0.030 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2013 | 9 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 412 | 0.030 |
Why?
|
| Cholesterol | 1 | 2014 | 252 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2016 | 605 | 0.020 |
Why?
|
| Catalase | 1 | 2011 | 15 | 0.020 |
Why?
|
| Diet, Atherogenic | 1 | 2011 | 62 | 0.020 |
Why?
|
| Superoxide Dismutase | 1 | 2011 | 45 | 0.020 |
Why?
|
| Cell Division | 1 | 2011 | 99 | 0.020 |
Why?
|
| Ferritins | 1 | 2011 | 47 | 0.020 |
Why?
|
| Heme Oxygenase-1 | 1 | 2011 | 33 | 0.020 |
Why?
|
| Sex Factors | 1 | 2013 | 667 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 153 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2013 | 251 | 0.020 |
Why?
|
| Amyloidosis | 1 | 2010 | 14 | 0.020 |
Why?
|
| Dogs | 1 | 2010 | 120 | 0.020 |
Why?
|
| Leptin | 1 | 2010 | 71 | 0.020 |
Why?
|
| Eating | 1 | 2010 | 74 | 0.020 |
Why?
|
| Fluorine Radioisotopes | 1 | 2009 | 19 | 0.020 |
Why?
|
| Fluorobenzenes | 1 | 2009 | 19 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2011 | 231 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2010 | 161 | 0.020 |
Why?
|
| Reference Values | 1 | 2009 | 246 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2010 | 238 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2008 | 3 | 0.020 |
Why?
|
| Exercise | 1 | 2014 | 673 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 62 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 743 | 0.020 |
Why?
|
| Rats | 1 | 2010 | 1596 | 0.020 |
Why?
|
| Cercopithecidae | 1 | 2006 | 10 | 0.020 |
Why?
|